Page last updated: 2024-09-05

gr 144053 and adenosine monophosphate

gr 144053 has been researched along with adenosine monophosphate in 1 studies

Compound Research Comparison

Studies
(gr 144053)
Trials
(gr 144053)
Recent Studies (post-2010)
(gr 144053)
Studies
(adenosine monophosphate)
Trials
(adenosine monophosphate)
Recent Studies (post-2010) (adenosine monophosphate)
211211,4322572,798

Protein Interaction Comparison

ProteinTaxonomygr 144053 (IC50)adenosine monophosphate (IC50)
Fructose-1,6-bisphosphatase 1Sus scrofa (pig)1.3
Fructose-1,6-bisphosphatase 1Homo sapiens (human)2.6436
Cytochrome P450 2C9 Homo sapiens (human)2.6
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.1
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)0.44
Histamine H3 receptorRattus norvegicus (Norway rat)0.8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishisaki, A; Kitajima, Y; Kozawa, O; Matsuno, H; Tokuda, H; Zhou, Y1

Other Studies

1 other study(ies) available for gr 144053 and adenosine monophosphate

ArticleYear
P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aged; Diabetes Mellitus, Type 2; Female; Humans; Male; Membrane Proteins; Middle Aged; Piperazines; Piperidines; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Reference Values

2005